首页> 美国政府科技报告 >Protein Biomarkers that Distinguish Prostate Cancer from Non-Malignant Cells.

【24h】

Protein Biomarkers that Distinguish Prostate Cancer from Non-Malignant Cells.

机译：蛋白质生物标志物区分前列腺癌与非恶性细胞。

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

This invention provides organic biomolecule markers (e.g., proteins) useful for differentiating prostate cancer, prostate intraepithelial neoplasia or benign prostate hyperplasia, from a negative diagnosis (i.e. normal and benign prostate epithelial cells).

著录项

作者
Wright, G. L.; Cazares, L. H.;
展开▼
作者单位

展开▼
年度 2003
页码 1-30
总页数 30
原文格式 PDF
正文语种
中图分类
关键词
Patent applications; Biomarkers; Proteins; Prostate cancer; Differentiation; Medical diagnosis; Cells(Biology); Organic biomolecule markers; Prostate intraepithelial neoplasia; Benign prostate hyperplasia; Negative diagnosis;

机译：专利申请;生物标志物;蛋白质;前列腺癌;分化;医学诊断;细胞（生物学）;有机生物分子标志物;前列腺上皮内瘤变;良性前列腺增生;阴性诊断;

相似文献

外文文献
中文文献
专利

1. Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer [J] . Andrej Jedinak, Adam Curatolo, David Zurakowski, BMC Cancer . 2015,第1期

机译：区分良性前列腺增生和前列腺癌的新型非侵入性生物标志物
2. STUDY OF GENES AS BIOMARKERS IN DISTINGUISH CANCEROUS FROM NORMAL TISSUE SAMPLES IN PROSTATE CANCER [J] . ramazi shahin, fasihi ali, abolhassanirziye, Majallah-i pizishki-i Urumiyah. . 2016,第6期

机译：前列腺癌与正常组织样本中癌基因的生物标志物研究
3. Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen [J] . FengJ., GangF., LiX., International Urology and Nephrology . 2013,第4期

机译：血浆无细胞DNA及其DNA完整性作为生物标志物，以区分血清前列腺特异性抗原增加的患者与前列腺癌与良性前列腺增生
4. Jumping Translocation Breakpoint (JTB) and Tumor Differentiation Factor (TDF) proteins as potential serum biomarkers for detecton of breast and prostate cancers [C] . Supriya Mathur, Izabela Sokolowska, Melissa Butkiewicz, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

机译：跳跃易位断点（JTB）和肿瘤分化因子（TDF）蛋白作为潜在的血清生物标志物，用于检测乳腺癌和前列腺癌
5. Development of novel biomarkers in cancer: Detection of circulating miR-141 as a potential prognostic marker for prostate cancer. [D] . Gonzales, Jason Cadaoas. 2010

机译：癌症中新型生物标志物的开发：检测循环miR-141作为前列腺癌的潜在预后标志物。
6. Autoantibody Signatures as Biomarkers to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia in Patients with Increased Serum Prostate Specific Antigen [O] . Dennis J. O’Rourke, Daniel A. DiJohnson, Robert J. Caiazzo Jr., -1

机译：自身抗体签名作为生物标志物以区分前列腺癌与血清前列腺特异性抗原患者患者的良性前列腺增生
7. Autoantibody Signatures as Biomarkers to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia in Patients with Increased Serum Prostate Specific Antigen [O] . Dennis J. O’rourke, Daniel A. Dijohnson, Robert J. Caiazzo, 2015

机译：自身抗体签名作为生物标志物，以区分前列腺癌与血清前列腺特异性抗原增加患者的良性前列腺增生
8. Identification and Characterization of Prostate Cancer Associated Protein Biomarkers Using High-Throughput Mass Spectrometry [R] . Malik, G. 2007

机译：使用高通量质谱法鉴定和表征前列腺癌相关蛋白质生物标志物

Protein Biomarkers that Distinguish Prostate Cancer from Non-Malignant Cells.

摘要

著录项

相似文献

相关主题

期刊订阅